Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1127449.RA5QmnUUBkASorNhKjdFxckx1ngimeGj9iC2Yx2tuh3Ew130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1127449.RA5QmnUUBkASorNhKjdFxckx1ngimeGj9iC2Yx2tuh3Ew130_assertion type Assertion NP1127449.RA5QmnUUBkASorNhKjdFxckx1ngimeGj9iC2Yx2tuh3Ew130_head.
- NP1127449.RA5QmnUUBkASorNhKjdFxckx1ngimeGj9iC2Yx2tuh3Ew130_assertion wasGeneratedBy ECO_0000203 NP1127449.RA5QmnUUBkASorNhKjdFxckx1ngimeGj9iC2Yx2tuh3Ew130_provenance.
- NP1127449.RA5QmnUUBkASorNhKjdFxckx1ngimeGj9iC2Yx2tuh3Ew130_assertion wasDerivedFrom befree-2016 NP1127449.RA5QmnUUBkASorNhKjdFxckx1ngimeGj9iC2Yx2tuh3Ew130_provenance.
- NP1127449.RA5QmnUUBkASorNhKjdFxckx1ngimeGj9iC2Yx2tuh3Ew130_assertion SIO_000772 24222153 NP1127449.RA5QmnUUBkASorNhKjdFxckx1ngimeGj9iC2Yx2tuh3Ew130_provenance.
- NP1127449.RA5QmnUUBkASorNhKjdFxckx1ngimeGj9iC2Yx2tuh3Ew130_assertion evidence source_evidence_literature NP1127449.RA5QmnUUBkASorNhKjdFxckx1ngimeGj9iC2Yx2tuh3Ew130_provenance.
- NP1127449.RA5QmnUUBkASorNhKjdFxckx1ngimeGj9iC2Yx2tuh3Ew130_assertion description "[Clinical significance of erlotinib monotherapy for gefitinib-resistant non-small cell lung cancer with EGFR mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1127449.RA5QmnUUBkASorNhKjdFxckx1ngimeGj9iC2Yx2tuh3Ew130_provenance.